Greedy Insider
TARS Insider Trades and Greediness Scores
Tarsus Pharmaceuticals, Inc. (TARS) insider trades: since Dec 15, 2025, Greedy Insider recorded 0 open-market buys and 59 sales on Form 4 from 9 insiders. The strongest recent filing scored 88 (Strong).
Who bought and who sold
Across the last 59 scoreable Form 4 transactions in TARS, 0 were open-market purchases and 59 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| LINK WILLIAM J PHD | Director | Sell | 11675.0 | 914502.75 | 2026-09-15 | 74 | View |
| LINK WILLIAM J PHD | Director | Sell | 759.0 | 59961.0 | 2026-09-15 | 57 | View |
| LINK WILLIAM J PHD | Director | Sell | 66.0 | 5280.66 | 2026-09-15 | 57 | View |
| Lin Elizabeth Yeu | Chief Medical Officer | Sell | 1590.0 | 135150.0 | 2026-09-04 | 67 | View |
| Lin Elizabeth Yeu | Chief Medical Officer | Sell | 5387.0 | 457895.0 | 2026-09-04 | 80 | View |
| Lin Elizabeth Yeu | Chief Medical Officer | Sell | 5386.0 | 484740.0 | 2026-09-04 | 81 | View |
| Lin Elizabeth Yeu | Chief Medical Officer | Sell | 1590.0 | 143100.0 | 2026-09-04 | 67 | View |
| Neervannan Seshadri | COO | Sell | 4564.0 | 387940.0 | 2026-09-04 | 76 | View |
| Azamian Bobak R. | President | Sell | 7100.0 | 640917.0 | 2026-09-04 | 72 | View |
| Azamian Bobak R. | President | Sell | 2900.0 | 264683.0 | 2026-09-04 | 65 | View |
The strongest recent filing
Azamian Bobak R. (President) sold 11,964 shares of Tarsus Pharmaceuticals, Inc. on Mar 19, 2026, a filing that scored 88 (Strong). It scored Strong because a senior insider was trading and several insiders moved the same way within a week. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 8 insiders (Neervannan Seshadri, Whitfield Dianne C., Wahl Bryan, Mottiwala Aziz) traded TARS the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with Tarsus Pharmaceuticals, Inc.'s own history
Open-market buys make up 0% of the 59 scoreable TARS transactions on record between Dec 15, 2025 and Sep 15, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 59
- Open-market buys: 0
- Sales: 59
- Distinct insiders: 9
- Strongest recent Greediness Score: 88 (Strong)
Primary sources
Related
- Strongest filing
- TARS in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.